Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Clementine is a specialized network of residential eating disorder treatment programs designed specifically for adolescent girls and gender-expansive youth. Operating as a key brand under the Monte Nido & Affiliates umbrella, the company provides a high level of medical and psychiatric care within a home-like, intimate setting. Their clinical model integrates evidence-based therapies, such as Dialectical Behavior Therapy (DBT) and Cognitive Behavioral Therapy (CBT), with nutritional rehabilitation and academic support. Clementine focuses on treating complex cases of anorexia nervosa, bulimia nervosa, and binge eating disorder, aiming to bridge the gap between acute hospital care and traditional residential treatment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Clementine Treatment Programs.